| Authors: |
Ackermann-Gäumann R; Microbiologie, ADMED Analyses et Diagnostics Médicaux, Boucle de Cydalise 16, CH-2600 La Chaux-de-Fonds, Switzerland; Swiss National Reference Center for Tick-Transmitted Diseases, Boucle de Cydalise 16, CH-2600 La Chaux-de-Fonds, Switzerland. Electronic address: rahel.ackermann@itransfusion.ch., Niederhauser C; Interregional Blood Transfusion SRC, Murtenstrasse 133, CH-3008 Bern, Switzerland; Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 25, CH-3001 Bern, Switzerland., Gowland P; Interregional Blood Transfusion SRC, Murtenstrasse 133, CH-3008 Bern, Switzerland., Angulo FJ; Global Vaccines and Anti-infectives Medical Affairs, Pfizer Inc., Collegeville, 500 Arcola Road, PA 19426, USA., Loew-Baselli A; Global Vaccines and Anti-infectives Medical Affairs, Pfizer Corporation Austria, Floridsdorfer Hauptstrasse 1, A-1210 Vienna, Austria., Brestrich G; Global Vaccines and Anti-infectives Medical Affairs, Pfizer Pharma GmbH, Friedrichstrasse 110, DE-10117 Berlin, Germany., Tan Y; Evidence Generation Statistics, Pfizer Inc., 1 Portland Street, Cambridge, MA 02139, USA., Covi M; Vaccines and Antivirals Medical Affairs, Pfizer AG, Schärenmoosstrasse 99, CH-8052 Zürich, Switzerland., Pilz A; Global Vaccines and Anti-infectives Medical Affairs, Pfizer Corporation Austria, Floridsdorfer Hauptstrasse 1, A-1210 Vienna, Austria., Stark J; Global Vaccines and Anti-infectives Medical Affairs, Pfizer Inc., 1 Portland Street, Cambridge, MA 02139, USA., Croxatto A; Microbiologie, ADMED Analyses et Diagnostics Médicaux, Boucle de Cydalise 16, CH-2600 La Chaux-de-Fonds, Switzerland; Swiss National Reference Center for Tick-Transmitted Diseases, Boucle de Cydalise 16, CH-2600 La Chaux-de-Fonds, Switzerland., Lienhard R; Microbiologie, ADMED Analyses et Diagnostics Médicaux, Boucle de Cydalise 16, CH-2600 La Chaux-de-Fonds, Switzerland; Swiss National Reference Center for Tick-Transmitted Diseases, Boucle de Cydalise 16, CH-2600 La Chaux-de-Fonds, Switzerland. |
